| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 03/14/2001 | CN1287009A Sucked insulin preparation |
| 03/14/2001 | CN1287007A Preparation of freeze-dried spirulina powder containing diabetes resisting factor |
| 03/14/2001 | CN1287004A Compound diabetes-treating Chinese medicine preparation |
| 03/14/2001 | CN1286924A Antilipemic beverage or tea |
| 03/14/2001 | CN1063180C 5H, 10H-imidazo [1,2-a] indeno [1,2-e] pyrazin-4-one derivatives, preparation thereof, and drugs containing said derivatives |
| 03/14/2001 | CN1063176C Chromone derivative |
| 03/13/2001 | USRE37094 Heterocyclic substituted acylaminothiazoles, their preparation and pharmaceutical compositions containing them |
| 03/13/2001 | US6201025 For treatment of central nervous system disorders |
| 03/13/2001 | US6201020 Effective poly(adenosine 5'-diphospho-ribose) polymerase (parp) inhibitor for treatment of tissue damage by necrosis or apoptosis; side effect reduction |
| 03/13/2001 | US6201004 Dioxino derivatives and their use as therapeutic agents |
| 03/13/2001 | US6200995 Pyridyloxybenzenesulfonamide derivatives; diabetes, obesity |
| 03/13/2001 | US6200979 Administering substituted pyrazoles and pyzazolopyrimidines for treating phobias obsessive-compulsive disorder, post-traumatic stress disorder, single episode depression, recurrent depression, dysthymia, bipolar disorders |
| 03/13/2001 | US6200971 For treating atherosclerosis |
| 03/13/2001 | US6200955 Heparin binding peptides |
| 03/13/2001 | US6200950 Nutritional suppliment |
| 03/13/2001 | US6200807 Antisense inhibition of SHP-2 expression |
| 03/13/2001 | US6200775 Nucleotide sequence coding a polypeptide associated with the diagnosis and treatment of infections |
| 03/13/2001 | US6200624 Controlling concentration of proteins, carbohydrates and fats; infants |
| 03/13/2001 | US6200599 Ortho ester lipids |
| 03/13/2001 | US6200569 Water extract or a dilute acidic extract of polygonum multiform roots or cinnamomum bark; decreasing the glycosylated hemoglobin level or blood glucose level in a hyperglycemic patient |
| 03/13/2001 | US6200563 Synthetic mammalian sulphamidase and genetic sequences encoding same |
| 03/08/2001 | WO2001017211A2 Communications system |
| 03/08/2001 | WO2001016603A2 Analysis and treatment of body weight and eating disorders |
| 03/08/2001 | WO2001016575A1 Glucose biosensor |
| 03/08/2001 | WO2001016358A2 Method of screening for triacyglycerol hydrolase inhibitors |
| 03/08/2001 | WO2001016345A2 Sequence-specific dna recombination in eukaryotic cells |
| 03/08/2001 | WO2001016319A2 Compositions and methods for the treatment of immune related diseases |
| 03/08/2001 | WO2001016312A2 Nucleic acid based modulators of gene expression |
| 03/08/2001 | WO2001016297A1 Dna encoding a human subunit 5-ht3-c of the 5-ht3 serotonin receptor |
| 03/08/2001 | WO2001016147A1 Glucopyranosyloxypyrazole derivatives, medicinal compositions containing the same and intermediates in the production thereof |
| 03/08/2001 | WO2001016137A1 Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage |
| 03/08/2001 | WO2001016136A2 Tricyclic inhibitors of poly(adp-ribose) polymerases |
| 03/08/2001 | WO2001016135A2 Reverse-turn mimetics and methods relating thereto |
| 03/08/2001 | WO2001016133A2 8-substituted-6-trifluoromethyl-9-pyrido[3,2-g]quinoline compounds as androgen receptor modulators |
| 03/08/2001 | WO2001016128A1 Dibenzopyrans as glucocorticoid receptor antagonists for treatment of diabetes |
| 03/08/2001 | WO2001016123A1 Benzylidene-thiazolidinediones and analogues and their use in the treatment of inflammation |
| 03/08/2001 | WO2001016122A1 Benzylidene-thiazolidinediones and analogues and their use in the treatment of diabetes |
| 03/08/2001 | WO2001016121A1 Heterocyclic compounds and methods of use thereof |
| 03/08/2001 | WO2001016120A1 Biaryl-oxa(thia)zole derivatives and their use as ppars modulators |
| 03/08/2001 | WO2001016119A1 Hypoglycemic n,n-arylsulfonylglycine compounds |
| 03/08/2001 | WO2001016114A2 Heterocyclic compounds and methods for modulating cxcr3 function |
| 03/08/2001 | WO2001016099A1 VITAMIN D DERIVATIVES HAVING SUBSTITUENTS AT THE 2α-POSITION |
| 03/08/2001 | WO2001016097A1 Phosphate mimics and methods of treatment using phosphatase inhibitors |
| 03/08/2001 | WO2001016096A2 Use of bis-sulfonamides for producing medicaments used for preventing or treating hyperlipidaemia |
| 03/08/2001 | WO2001016094A1 Sulfonyl carboxamide derivatives, method for their production and their use as medicaments |
| 03/08/2001 | WO2001016093A1 SUBSTITUTED α-HYDROXY ACID CASPASE INHIBITORS AND THE USE THEREOF |
| 03/08/2001 | WO2001015720A1 Methods and compositions for reducing serum phosphate levels |
| 03/08/2001 | WO2001015718A1 Extracts derived from pueraria mirifica, butea superba and/or mucuna collettii and extraction thereof |
| 03/08/2001 | WO2001015693A2 Treatment of migraine by the administration of alpha-lipoic acid or derivatives thereof |
| 03/08/2001 | WO2001015689A1 Use of amino acids for making medicines for treating to insulin-resistance |
| 03/08/2001 | WO2001015676A2 Compositions and methods for modulating hdl cholesterol and triglyceride levels |
| 03/08/2001 | WO2001015674A2 Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular events |
| 03/08/2001 | WO2001015673A2 Pharmaceutical formulations and use thereof in the prevention of stroke, diabetes and/or congestive heart failure |
| 03/08/2001 | WO2001015668A1 Controlled release pellet formulation |
| 03/08/2001 | WO2001015666A1 Mixed micellar pharmaceutical delivery system and method of preparation |
| 03/08/2001 | WO2001000588A8 Benzimidazole compounds and drugs containing the same |
| 03/08/2001 | WO2000078751A3 Compounds for use in treatment of neurological disorders |
| 03/08/2001 | WO2000062767A3 Pharmaceutical compositions containing pyridine or pyrimidine derivates for inhibition of cytokine production and secretion |
| 03/08/2001 | WO2000059885A8 Method for the preparation of tricyclic amino alcohol derivatives through azides |
| 03/08/2001 | WO2000059506A8 HETEROCYCLIC CONTAINING BIPHENYL aP2 INHIBITORS AND METHOD |
| 03/08/2001 | WO2000059448A3 Association of no-synthase inhibitor(s) and metabolic antioxidant(s) |
| 03/08/2001 | WO2000049137A3 Pluripotential cell derived from an embryonic stem cell and a nucleus of a somatic cell |
| 03/08/2001 | WO2000041546A9 Novel exendin agonist formulations and methods of administration thereof |
| 03/08/2001 | WO2000039283A8 Use of cd40 engagement to alter t cell receptor usage |
| 03/08/2001 | DE19942417A1 Orally administered composition for obtaining satiation effect and/or improving gastric function, containing crosslinked uronic acid-containing polysaccharide in sponge form |
| 03/08/2001 | DE19942354A1 Substituierte 3-Phenyl-5-alkoxi-1,3,4-oxdiazol-2-one, ihre Herstellung und Verwendung in Arzneimitteln Substituted 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-ones, their preparation and use in medicaments |
| 03/08/2001 | CA2403243A1 Nucleic acid based modulators of gene expression |
| 03/08/2001 | CA2387507A1 Communications system |
| 03/08/2001 | CA2384194A1 Benzylidene-thiazolidinediones and analogues and their use in the treatment of inflammation |
| 03/08/2001 | CA2384126A1 Reverse-turn mimetics and methods relating thereto |
| 03/08/2001 | CA2384055A1 Compositions and methods for the treatment of immune related diseases |
| 03/08/2001 | CA2384026A1 Dna encoding a human subunit 5-ht3-c of the 5-ht3 serotonin receptor |
| 03/08/2001 | CA2383783A1 Use of bis-sulfonamides for producing medicaments used for preventing or treating hyperlipidaemia |
| 03/08/2001 | CA2383781A1 Sulfonyl carboxamide derivatives, method for their production and their use as medicaments |
| 03/08/2001 | CA2383381A1 Methods and compositions relating to body weight and eating disorders |
| 03/08/2001 | CA2383347A1 Benzylidene-thiazolidinediones and analogues and their use in the treatment of diabetes |
| 03/08/2001 | CA2383002A1 Substituted .alpha.-hydroxy acid caspase inhibitors and the use thereof |
| 03/08/2001 | CA2382966A1 Biaryl-oxa(thia)zole derivatives and their use as ppars modulators |
| 03/08/2001 | CA2382835A1 Use of amino acids for making medicines for treating to insulin-resistance |
| 03/08/2001 | CA2382789A1 Phosphate mimics and methods of treatment using phosphatase inhibitors |
| 03/08/2001 | CA2382562A1 Compositions and methods for modulating hdl cholesterol and triglyceride levels |
| 03/08/2001 | CA2381713A1 Methods and compositions for reducing serum phosphate levels |
| 03/08/2001 | CA2381239A1 Dibenzopyrans as glucocorticoid receptor antagonists for treatment of diabetes |
| 03/08/2001 | CA2378298A1 8-substituted-6-trifluoromethyl-9-pyrido¬3,2-g|quinoline compounds as androgen receptor modulators |
| 03/07/2001 | EP1081137A1 Selective inhibitors of aggrecanase in osteoarthritis treatment |
| 03/07/2001 | EP1081135A2 1H-indole-3-glyoxylamide spla2 inhibitors |
| 03/07/2001 | EP1080726A1 Agents for relieving side effects |
| 03/07/2001 | EP1080676A1 Home-style decoctor endowed with steamy boiling function, and method of preparing red ginseng extract using the same |
| 03/07/2001 | EP1080209A2 Methods of treatment of type 2 diabetes |
| 03/07/2001 | EP1080203A2 Human hydrolase homologs: n-terminal asparagine amidohydrolase, glycosyl hydrolase, glucohydrolase, biotinidase, and n-acetylglucosamine 6-p deacetylase |
| 03/07/2001 | EP1080194A2 Human transmembrane proteins |
| 03/07/2001 | EP1080189A1 Compositions and methods for the synthesis of fatty acids, their derivatives and downstream products |
| 03/07/2001 | EP1080180A2 Secreted proteins and polynucleotides encoding them |
| 03/07/2001 | EP1080095A1 Modulators of protein tyrosine phosphatases (ptpases) |
| 03/07/2001 | EP1080091A1 Novel 1,3,8-triazaspiro[4.5]decanones with high affinity for opioid receptor subtypes |
| 03/07/2001 | EP1080087A1 Novel 2-alkyl substituted imidazole compounds |
| 03/07/2001 | EP1080068A1 Modulators of protein tyrosine phosphatases |
| 03/07/2001 | EP1080055A2 24-hydroxyvitamin d, analogs and uses thereof |
| 03/07/2001 | EP1079841A1 Method of extracting antioxidants from labiate species and the extract products thereof |
| 03/07/2001 | EP1079833A1 Cocaine receptor binding ligands |